RETA
Reata Pharmaceuticals Inc
General Counsel Michael D Wortley sold $35K of Reata Pharmaceuticals Inc
Sold$34,966
$84.46Price
414Shares
−1%Stake
What RETA did after the filing
- The stock from Wed, Mar 8 close, $83.96
- +18.9%
- S&P 500, same days
- +3.6%
Measured over 30 trading days, to the Apr 20 close.
Traded Tue, Mar 7. Filed Wed, Mar 8, 11:59 AM ET, during the session. Returns use the Mar 8 close and the Apr 20 close. Not investment advice.